Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p> <span _fck_bookmark="1" style="display: none;">&nbsp;</span>Evidence-based updates in clinical pharmacology</p> <p> <span style="color: rgb(85, 85, 85); font-family: Arial, Helvetica, sans-serif; font-size: 14px; line-height: 21px;">In this issue: Treating Community-Acquired Pneumonia; 4-month vs 6-month Therapy for Tuberculosis; Green Coffee Bean Study Retracted; Fecal Microbiota Transplant for&nbsp;</span><span class="Italics" style="border: 0px; font-family: Arial, Helvetica, sans-serif; font-size: 14px; font-stretch: inherit; line-height: 21px; margin: 0px; padding: 0px; vertical-align: baseline; color: rgb(85, 85, 85);"><em style="border: 0px; font-family: inherit; font-size: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;">C. difficile</em>&nbsp;</span><span style="color: rgb(85, 85, 85); font-family: Arial, Helvetica, sans-serif; font-size: 14px; line-height: 21px;">Infection; and FDA Actions.</span></p>

Stick with Two Drugs for Sicker Patients with Pneumonia

Treating Community-Acquired Pneumonia